CardioMEMS HF System Real-World Evidence Post-Approval Study
NCT: NCT06306573 · ENROLLING_BY_INVITATION
NCT IDNCT06306573
StatusENROLLING_BY_INVITATION
Start Date2022-12-15
Completion2029-12-31
SponsorAbbott Medical Devices (INDUSTRY)
First posted
Last updated
Brief Summary
The purpose of this post-approval study (PAS) is to evaluate the long-term safety and effectiveness of the CardioMEMS™ HF System using real-world evidence (RWE) methods.
Frequently Asked Questions
What is CardioMEMS HF System Real-World Evidence Post-Approval Study?
CardioMEMS HF System Real-World Evidence Post-Approval Study is a clinical trial registered under NCT06306573. Current status: ENROLLING_BY_INVITATION.
What is the status of NCT06306573?
The current status of NCT06306573 (CardioMEMS HF System Real-World Evidence Post-Approval Study) is: ENROLLING_BY_INVITATION.
When did CardioMEMS HF System Real-World Evidence Post-Approval Study start?
CardioMEMS HF System Real-World Evidence Post-Approval Study started on 2022-12-15.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.